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The Emb proteins (EmbA, EmbB, EmbC) are mycobacterial arabinosyltransferases involved in
the biogenesis of the mycobacterial cell wall. EmbA and EmbB are predicted to work in unison as
a heterodimer. EmbA and EmbB are involved in the formation of the crucial terminal
hexaarabinoside motif [Arab(1A2)Araa(1A5)][ Arab(1A2)Araa(1A3)]Araa(1A5)Araa1A(Ara6)
in the cell wall polysaccharide arabinogalactan. Studies conducted in Mycobacterium smegmatis
revealed that mutants with disruptions in embA or embB are viable, although the growth rate
was affected. In contrast, we demonstrate here that embA is an essential gene in Mycobacterium
tuberculosis, since a deletion of the chromosomal gene could only be achieved when a second
functional copy was provided on an integrated vector. Complementation of an embA mutant of
M. smegmatis by M. tuberculosis embA confirmed that it encodes a functional
arabinosyltransferase. We identified a promoter for M. tuberculosis embA located immediately
upstream of the gene, indicating that it is expressed independently from the upstream gene,
embC. Promoter activity from PembA(Mtb) was sevenfold lower when assayed in M. smegmatis
compared to M. tuberculosis, indicating that the latter is not a good host for genetic analysis of M.
tuberculosis embA expression. PembA(Mtb) activity remained constant throughout growth phases
and after stress treatment, although it was reduced during hypoxia-induced non-replicating
persistence. Ethambutol exposure had no effect on PembA(Mtb) activity. These data demonstrate
that M. tuberculosis embA encodes a functional arabinosyltransferase which is constitutively
expressed and plays a critical role in M. tuberculosis.
INTRODUCTION
Mycobacterium tuberculosis poses a serious global health
problem, causing millions of deaths and new infections
every year. There is an urgent need for new antimyco-
bacterial therapeutics, since the current treatment regimen
is lengthy and ineffective against multi-drug-resistant
strains. The cell wall of M. tuberculosis is an attractive
drug target, since it is critical for cell survival and a number
of current antitubercular agents target this structure. In
mycobacteria, the peptidoglycan, located immediately
outside the cytoplasmic membrane, is covalently attached
to arabinogalactan (AG), which is in turn esterified to the
mycolic acid layer. This structure, called the mycolyl-AG-
peptidoglycan (mAGP) complex, forms the core frame-
work of the mycobacterial cell wall. The wall provides a
hydrophobic permeability barrier and is responsible for at
least part of the intrinsic resistance of mycobacteria to a
number of antibiotics (Brennan, 2003).
Arabinosyltransferases, encoded by emb genes, play key
roles in the synthesis of mycobacterial cell wall compo-
nents. Two emb genes (embA and embB) were initially
identified in Mycobacterium avium (Belanger et al., 1996).
Subsequently, three Emb proteins have been identified in
M. tuberculosis (Cole et al., 1998) and in Mycobacterium
smegmatis (Escuyer et al., 2001); no orthologues have been
identified elsewhere than in the order Actinomycetales. The
genomic arrangement of the emb genes in M. tuberculosis
and M. smegmatis is similar, with the three genes
(embCAB) being co-localized and possibly being tran-
scribed as an operon (Telenti et al., 1997).
The Emb proteins form a family of large (.1100 residues)
transmembrane proteins with a cytoplasmic N-terminal
domain, 13–15 transmembrane segments and a large
extracytoplasmic C-terminal domain (Berg et al., 2003;
Seidel et al., 2007). Emb proteins are considered to be good
Abbreviations: AG, arabinogalactan; DCO, SCO, double, single cross-
over; del-int, one deleted copy and one integrated copy of embA;
HPAEC, high-pH anion-exchange chromatography; LAM, lipoarabino-
mannan; mAGP, mycolyl-AG-peptidoglycan (complex); OADC, oleic acid,
albumin, dextrose, catalase.
Microbiology (2008), 154, 240–248 DOI 10.1099/mic.0.2007/012153-0
240 2007/012153 G 2008 SGM Printed in Great Britaindrug targets, since the current antitubercular drug,
ethambutol, causes cessation of the synthesis of arabinan
polymers [AG and lipoarabinomannan (LAM)]. This is due
to the inhibition of arabinosyltransferases (Khoo et al.,
1996; Mikusova et al., 1995) and embB mutations have
been associated with ethambutol resistance in M. tuber-
culosis (Sreevatsan et al., 1997).
Almost all of the work characterizing the role and
expression of Emb proteins has been carried out in the
saprophytic species M. smegmatis where the role of each
protein has been determined. Biochemical analyses of
deletion mutants has clearly shown that the Emb proteins
are all arabinosyltransferases, but with segregated biological
functions. EmbC is involved in the biosynthesis of the
arabinan portion of LAM (Zhang et al., 2003), whereas
EmbA and EmbB are involved in AG synthesis (Escuyer
et al., 2001). Thus, the crucial hexaarabinoside terminal
motif, which is the structural motif for mycolylation in AG
(McNeil et al., 1994), is altered in both M. smegmatis embA
and embB mutants (Escuyer et al., 2001). An EmbA
deletion mutant has a number of other phenotypic
changes, including altered morphology, slight loss of
acid-fastness and increased susceptibility to hydrophobic
antibiotics (Escuyer et al., 2001). These changes are likely
to be a direct result of the defective synthesis of AG in the
cell wall.
No direct information on the role of M. tuberculosis EmbA
(EmbAMtb) has been obtained to date and there is no
information on the expression of the embA gene or its
promoter in this species. To determine the function of
EmbAMtb, we attempted to construct a deletion mutant by
gene replacement. We demonstrate here that embA is
essential in M. tuberculosis under normal culture condi-
tions. EmbAMtb was confirmed as a bona fide arabinosyl-
transferase, since it was able to complement an M.
smegmatis embA mutant in an in vitro assay. We also
identified the promoter of embA and demonstrated that its
expression is constitutive.
METHODS
Culture. Mycobacteria were grown in Middlebrook liquid medium
(7H9-OADC) [4.7 g Middlebrook 7H9 l
21 plus 10% (v/v) OADC
(oleic acid, albumin, dextrose, catalase) supplement (Becton
Dickinson)] with 0.05% (w/v) Tween 80 (Tw) where stated, or on
Middlebrook solid medium (7H10-OADC) [19 g Middlebrook 7H10
l
21 plus 10% (v/v) OADC supplement]. Dubos medium supple-
mented with 5% (w/v) glycerol and 10% (v/v) Dubos medium
albumin (Becton Dickinson) was used for hypoxic cultures. Aerobic
liquid cultures of M. tuberculosis were static 10 ml cultures,
inoculated 1:10 in 50 ml tubes. Hypoxic cultures were performed
in 17 ml medium in 20 mm glass tubes with slow stirring (50 r.p.m.)
from a starting OD570 of 0.004. Kanamycin was used at 20 mgm l
21,
hygromycin at 100 mgm l
21, streptomycin at 20 mgm l
21, gentamicin
at 10 mgm l
21, X-Gal at 50 mgm l
21 and sucrose at 5% (w/v) unless
otherwise indicated.
Construction of embA deletion vector. A deletion delivery vector
for embA was constructed as follows: the upstream and downstream
regions of embA were amplified using primer pairs F1 (59-
ATCGCAGTTTCCTCAACGAC-39) and R1 (59-CCTCGAGGGATC-
GAGATGTCCAG-39), and F2 (59-CTCGAGGTCGTCGAACCTAT-
GGCAGT-39) and R2 (59-AGCGCCAGCAGGTTGTAATA-39),
respectively, and cloned into pGEM-T Easy (Promega). XhoI
restriction sites (underlined) were engineered into the primers. The
two fragments were excised as KpnI–XhoI and XhoI–BamHI
fragments and cloned into p2NIL (Parish & Stoker, 2000). The
lacZ, sacB, hyg cassette from the marker cassette vector pGOAL19
(Parish & Stoker, 2000) was excised as a PacI fragment and inserted
into p2NIL to make the final vector, pEMPTY16.
Attempts to construct an embA deletion strain. Plasmid
pEMPTY16 was pre-treated with UV to promote homologous
recombination and electroporated into M. tuberculosis (Hinds et al.,
1999). Single cross-overs (SCOs) were isolated on hygromycin,
kanamycin and X-Gal plates. One SCO was streaked onto solid
medium without antibiotics to allow the second cross-over to occur.
Double cross-overs (DCOs) were isolated on sucrose, X-Gal plates.
White colonies were patch-tested for kanamycin and hygromycin
sensitivity to confirm vector loss. A PCR screen using primers DIET1
(59-CATCCTCACCGCCCTTAAC-39) and DIET2 (59-CGATTTGG-
GGTGCTTTTG-39) was used to distinguish between wild-type
(3.4 kb band) and deletion DCOs (0.5 kb band).
Construction of embA merodiploid strain. The complementation
vector pEMPTY22 was constructed by amplifying the embA gene with
primers Empathy3 (59-TTAATTAATGGCCAGCTACCTCAAAGAC-
39) and Empathy4 (59-TTAATTAAACCGACAACACAAAGCCAAT-
39), cloning into pGEM-T Easy and subcloning into pAPA3 (L5
integrating vector with Ag85a promoter; unpublished) as a PacI
fragment (sites underlined) in the correct orientation for expression
from the Ag85a promoter. pEMPTY22 was transformed into the SCO
strain to generate a merodiploid strain (Tame 68). DCOs were
isolated from this strain by plating onto sucrose, X-Gal and
gentamicin. Sucrose-resistant, white colonies were screened by PCR
as before. ‘Del-int ’ DCO strains (one deleted copy and one integrated
copy of embA) were isolated and confirmed by Southern analysis. For
gene switching, two del-int strains [embAD (PAg85a-embA,L 5int, Gm)]
were transformed with the integrating vector pUC-Hyg-Int
(Mahenthiralingam et al., 1998). Transformants were plated on
hygromycin±gentamicin and patch-tested for hygromycin/gentami-
cin resistance.
Analyses of promoter activity. The intergenic region between embC
and embA of M. tuberculosis was amplified using primers 59-CCCA-
GTACTAGCGGTTGACGCCTTACTAC-39 and 59-CCCAGTACTAG-
ATCGCTCATTACCGTCGT-39, cloned as a ScaI fragment (sites
underlined) into the L5-based integrating vector pSM128 (Dussurget
et al., 1999) upstream of the promoterless lacZ gene to make plasmid
pEMBA and the sequence verified. For site-directed mutagenesis,
primers SDM1 (59-CGC GTC GCC GAC CAG CGA GCC TCG-39)
and SDM2 (59-CGA GGC TCG CTG GTC GGC GAC GCG-39)
(mutated nucleotides underlined) were used to generate a double
mutation. The amplification reaction for site-directed mutagenesis
was carried out in 50 ml total volume containing 16 Pfu Ultra
reaction buffer, 0.5 mM dNTPs, 10 pmol each primer, 10% DMSO,
10 ng template and 2.5 units Pfu Ultra (Stratagene). The thermo-
cycling programme used was 95 uC for 1 min, followed by 18 cycles of
95 uC for 1 min, 60 uC for 1 min, 68 uC for 12 min and a final
extension cycle at 68 uC for 20 min. The template was degraded using
10 units DpnIa t3 7uC for 1 h. Five microlitres of the reaction was
then used to transform competent Escherichia coli. Recombinant
pEMBA-M plasmid was isolated and the sequence verified. Plasmids
pEMBA and pEMBA-M were electroporated into M. smegmatis and
M. tuberculosis and streptomycin-resistant transformants were
isolated. Three independent transformants for each were selected
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(Parish & Wheeler, 1998) and b-galactosidase assays were performed
as described by Miller (1972).
Isolation of RNA and identification of the embA transcript.
Total RNA was isolated from M. tuberculosis cells grown in 100 ml
7H9-OADC containing 0.05% (w/v) Tween 80 to an OD600 of 0.8.
The cells were pelleted at 3000 g for 10 min and resuspended in 10 ml
Trizol (Invitrogen), vortexed and frozen at –80 uC for 1 h. The cells
were broken in a FastPrep machine (Thermo Electron) at speed 6.0
for 40 s and the lysate was extracted with 2 ml chloroform. The cell
lysate was centrifuged at 27000 g at 4 uC for 30 min and the aqueous
layer was precipitated with 5 ml 2-propanol at 280 uC overnight, the
pellet being collected by centrifugation at 14000 g for 10 min at 4 uC,
washed with 70% ethanol, dried and dissolved in 100 ml RNase-free
water. The sample was then treated with 5 units RNase-free DNase for
1 h at 37 uC. After the removal of DNase by phenol/chloroform
extraction, the RNA was precipitated with ethanol and dissolved in
50 ml deionized RNase-free water. cDNA was generated using
Superscript III reverse transcriptase (RT) (Invitrogen) with the
primers EMBAR (59-CGATGGCCGAGCAGGGGATC-39) and
EMBBR (59-GGTCGGTGACGTCCACGCG-39). PCR was performed
using primer pairs EMBAR and EMBCF2 (59-GCGAGGTCCGGTT-
GCAGTGG-39), and EMBBR and EMBAF1 (59-CTGCCAGCG-
ACCGTTTTCC-39)i na5 0ml reaction using Taq DNA polymerase
and 2 ml cDNA from the first strand synthesis. The amplification was
performed with an initial denaturation at 94 uC for 5 min, followed
by 30 cycles of denaturation at 94 uC for 30 s, annealing at 55 uC for
30 s, and extension at 72 uC for 1 min, followed by a final extension
step at 72 uC for 7 min.
For Northern analysis, 16 mg total RNA from M. tuberculosis was
separated by gel electrophoresis using 1% agarose gel and transferred
to a positively charged nylon membrane (Amersham Hybond-N+)
for 1.5 h using the QBIOgene vacuum blotter. The PCR-amplified
embAMtb was purified and used as the hybridization probe. Labelling
and detection were carried out using the AlkPhos Direct kit
(Amersham), according to the manufacturer’s instructions.
Arabinosyltransferase assay. The 3285 bp embAMtb was amplified
from genomic DNA using the primers TAF1 (59-CCCCATATG-
GTGCCCCACGACGGTAAT-39) and TAR1 (59-CCCAAGCTTTC-
ATGGCAGCGCCCTGAT-39) and the 3279 bp embA gene from M.
smegmatis (embAMsm) was amplified from genomic DNA using the
primers TMF1 (59-CCCCATATGGTGCCGGGCGATGAACAG-39)
and TMR1 (59-CCCAAGCTTTCACGGCAGTGCCCTGAT-39) with
both primer sets having NdeI and HindIII restriction sites (under-
lined) in the forward and reverse primers, respectively. The amplified
genes were cloned into the pVV16 expression vector to make pTA and
pMA, respectively, and the sequences were verified. Plasmids pTA and
pMA were transformed into an embAMsm knockout strain
(DembAMsm) (Escuyer et al., 2001) to generate DembAMsm, com-
plemented with embAMtb, and DembAMsm, complemented with
embAMsm, respectively.
For the arabinosyltransferase assay, strains were grown to an OD600 of
0.8. Cell wall (P60) and membrane fractions were purified from the
strains by standard procedures (Khasnobis et al., 2006). The
arabinosyltransferase assay reaction mixture contained buffer A
(50 mM MOPS, pH 8.0, 5 mM b-mercaptoethanol, 10 mM
MgCl2), 1 mM ATP, 500000 d.p.m. p[
14C]Rpp (
14C-labelled phos-
phoribosylpyrophosphate, used as a donor to form decaprenylphos-
phoryl-D-[
14C]arabinose in situ) (Scherman et al., 1996), 300 mM
acceptor [pentasaccharide, octyl-b-D-Araf-(1A2)-a-D-Araf-(1A5)-a-
D-Araf-(1A5)-a-D-Araf-(1A5)-a-D-Araf, used as a substrate for
arabinosyltransferase activity in a cell-free assay] (Khasnobis et al.,
2006), 0.3 mg P60 and 0.8 mg membrane fractions in a total volume
of 200 ml. Reactions were incubated at 37 uC for 1 h, terminated by
adding 200 ml ethanol and centrifuged briefly at 14000 g, and the
supernatant was loaded onto a pre-packed strong anion exchange
(SAX) column (Burdick and Jackson) pre-equilibrated with 5 ml
water. Columns were eluted with 2 ml water, and the eluants were
dried and partitioned between the two phases (1:1) of water-
saturated 1-butanol and water, three times; the 1-butanol fractions
collected were air-dried, reconstituted in 200 ml 1-butanol and
measured by liquid scintillation spectrometry. 3000 d.p.m. were
analysed by silica gel TLC developed in CHCl3/CH3OH/1 M
NH4OAc/NH4OH/H2O (180:140:9:9:23), exposed for 5 days and
visualized using a phosphoimager (Molecular Dynamics). The
product was purified from the TLC, and approximately 5000 d.p.m.
of the product was treated with endoarabinanase isolated from
Cellulomonas gelida (McNeil et al., 1994) for 16 h at 37 uC (Khoo
et al., 1996) and subjected to Dionex high-pH anion-exchange
chromatography (HPAEC).
Preparation of LAM and soluble AG. Cells (10 g wet wt) were
delipidated with hot absolute ethanol followed by a 2:1 chloroform/
methanol extraction (Khoo et al., 1996). Delipidated cells were
resuspended in PBS and sonicated using Soniprep 150 (Sanyo, MSE
Ltd). The resulting suspension was extracted three times with 50%
ethanol and the 27000 g supernatants were combined, concentrated
and digested with 1 mg proteinase K ml
21. After dialysis, aliquots of
the aqueous solution containing LAM, lipomannan and phosphati-
dyl-myo-inositol mannosides were examined by SDS-PAGE. The
remainder was applied to a Sephacryl S-200 (Pharmacia) column as
described by Khoo et al. (1996). SDS-PAGE was used to monitor the
elution profile, and fractions that contained LAM were individually
pooled and dialysed. The cell-wall core mAGP complex was obtained
from the residual pellet after LAM, lipomannan and phosphatidyl-
myo-inositol mannoside extraction as described by Escuyer et al.
(2001). To release soluble AG from peptidoglycans, the insoluble
residue (mAGP complex) was treated with 2 M NaOH for 16 h at
80 uC and the soluble AG was purified as described by Daffe et al.
(1990).
GC and GC/MS analysis of glycosyl composition. Alditol acetates
for GC were prepared as described by McNeil et al. (1989). GC of the
alditol acetates was performed on an HP Gas Chromatograph Model
5890 fitted with an SP 2380 (30 m60.25 mm i.d.; Supelco) column
at an initial temperature of 50 uC, held for 1 min. The temperature
was raised to 170 uCa t3 0uC min
21 before increasing to 260 uCa t
5 uC min
21. For GC/MS, partially methylated alditol acetates were
dissolved in chloroform prior to injection on a DB-5 column
(10 m60.18 mm i.d.; J&W Scientific) using a ThermoQuest Trace
Gas Chromatograph 2000 (ThermoQuest) connected to a GCQ/
Polaris MS mass detector at an initial temperature of 50 uC held for
1 min. The temperature was raised to 150 uCa t3 0uC min
21 before
increasing to 260 uCa t5uC min
21.
RESULTS
embA is an essential gene in M. tuberculosis
We were interested in exploring the role of EmbA in M.
tuberculosis. Although data were available demonstrating its
function in M. smegmatis (Escuyer et al., 2001), nothing
was known of its function in M. tuberculosis. We first
attempted to make an embA deletion in M. tuberculosis
using a two-step recombination method (Parish & Stoker,
2000). The deletion vector carried an unmarked, in-frame
deletion of the majority of the embA gene to ensure that
any mutations did not affect expression of the downstream
A. G. Amin and others
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wild-type. This was unexpected, since gene knockouts of
embA were readily obtained in M. smegmatis (Escuyer et
al., 2001). To confirm essentiality, we constructed a
merodiploid strain carrying a second functional copy of
embA under the control of the constitutive Ag85a
promoter in an L5 integrating vector. In this background
we were able to isolate DCOs with both the deletion and
the wild-type allele (Fig. 1). Four out of 24 DCOs in the
merodiploid background were deletions, showing that
embA is an essential gene in M. tuberculosis (Fisher’s exact
t-test, P50.02). The genotype of the DCO strains was
confirmed by Southern blotting (Fig. 1c).
Gene switching
Since the essentiality of embA was not expected, we
confirmed our results using a second method (Pashley &
Parish, 2003). We showed that we could not replace the
integrated vector pEMPTY22 (embA, L5 int, Gm) when it
carried the only functional copy of embA. Two del-int
strains [Tame 91 and Tame 93: embAD (embA, L5 int, Gm)]
were transformed with an empty integrating vector pUC-
Hyg-Int (L5 int, hyg) and transformants were selected on
hygromycin. If the gene was non-essential, the incoming
vector would replace the resident integrated vector at a
high frequency and hygromycin-resistant (gentamicin-
sensitive) colonies would be isolated. If the gene was
essential, then only co-integrated strains (pEMPTY22 and
pUC-Hyg-Int) would be recovered; this occurs at a low
frequency and strains are gentamicin- and hygromycin-
resistant. We carried out this gene switching experiment
with two independent del-int strains (Tame 91 and Tame
93) (Table 1). The results indicated that replacement of
pEMPTY22 did not occur. The numbers of hygromycin-
resistant transformants were 10
2-t o1 0
3-fold lower with the
switching vector than with the control vector. In both
cases, 24 hygromycin-resistant colonies were patch-tested
and all were gentamicin-resistant, confirming that the
original plasmid containing embA was still present. Since
the resident vector could not be replaced, this further
confirms that embA is an essential gene in M. tuberculosis.
embAMtb encodes an arabinosyltransferase
embAMtb has been proposed to be an arabinosyltransferase
based on sequence homology with M. smegmatis embA
(Cole et al., 1998; Escuyer et al., 2001), although there is no
Fig. 1. Demonstration of essentiality of embA in M. tuberculosis. (a) The genomic organization of the embA region is shown.
The regions marked by black bars were amplified and cloned into p2NIL to generate the delivery vector pEMPTY16. The
promoter region assayed for activity is indicated by an arrow. (b) and (c) Southern analysis of recombinant strains. (b) The maps
of the wild-type and deletion mutant are shown, with the expected sizes. BamHI sites are indicated by symbols (0) and the
probe is shown as a solid bar. (c) No deletion DCOs were isolated in the wild-type background. PCR was used to screen for
potential deletion alleles in the merodiploid background and four potential del-int strains were identified. Genomic DNA from
these four strains was digested with BamHI and hybridized to the probe. The expected sizes for the wild-type and integrated
(int) copies of embA are given. Lanes: 1–4, genomic DNA from four del-int strains (deletion DCOs with integrated embA); W,
wild-type genomic DNA.
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vivo. We could not determine the biological consequences
of embA deletion in M. tuberculosis, since we were unable
to construct a deletion mutant. However, based on the
premises that EmbAMsm synthesizes or transfers a di-
saccharide Arab(1A2)Araa1A to an internal 5-linked Araf
of the linear glycan Arab(1A2)Araa(1A5)Araa(1A5)
Araa(1A5)Araa1A, we were able to use an enzyme assay
to identify the function of EmbAMtb.
Previous work has shown that an M. smegmatis embA
mutant is unable to transfer a disaccharide to the
pentasaccharide acceptor, but this function is restored by
complementation with functional EmbA (Khasnobis et al.,
2006). We tested whether complementing this mutant
strain with the embAMtb gene would restore this activity. As
a control, we also complemented with the embAMsm gene.
Enzyme preparations from the M. smegmatis strains were
used in a cell-free assay to detect arabinosyltransferase
activity. TLC analysis of the reaction products revealed a
slower migrating component as compared to the starting
acceptor in M. smegmatis embA strains complemented with
either M. smegmatis or M. tuberculosis alleles. The product
in both strains was indistinguishable (Fig. 2a), suggesting
that embAMtb encodes a functional arabinosyltransferase
with similar activity to EmbAMsm.
The mobility of the radioactive product does not indicate
the number of arabinosyl residues incorporated on the
pentasaccharide acceptor or the nature of the product. We
therefore subjected the purified radioactive product excised
from TLC to endoarabinanase digestion followed by
Dionex HPAEC. Oligosaccharides were eluted with a
gradient of sodium acetate (0–1 M) in 10% NaOH. The
Table 1. Gene switching to confirm essentiality
embA del-int strains (Tame 91 and Tame 93) were electroporated
with control vector (oriM, pAGAN40) or switching vector (pUC-
Hyg-Int) and transformants selected on hygromycin (H) or hygro-
mycin and gentamicin (HG). Transformation efficiencies per mg input
plasmid DNA are given. ND, Not determined.
Strain pAGAN40 pUC-Hyg-Int
HH GH H G
Tame 91 1.85E+08 2.18E+08 3.20E+05 2.15E+05
Tame 93 1.00E+07 ND 1.00E+05 ND
Fig. 2. Arabinosyltransferase activity assays.
Extracts from M. smegmatis strains were
prepared and used in an in vitro assay for
arabinosyltransferase activity. (a) TLC and (b)
Dionex HPAEC was used to analyse the
product formed after incubation with the
pentasaccharide acceptor. (a) TLC of M.
smegmatis strains. Wild-type (lanes 1 and 2),
DembA (3 and 4), DembA complemented with
embAMsm (5 and 6) and DembA complemen-
ted with embAMtb (7 and 8). Lanes 1, 3, 5 and
7 are reactions with the addition of an
acceptor pentasaccharide; lanes 2, 4, 6 and
8 are reactions with no acceptor. The acceptor
pentasaccharide (lane 9) was visualized on
TLC with a-naphthol. (b) The enzymically
formed radioactive product was purified from
the TLC plate and subjected to endoarabina-
nase digestion followed by Dionex HPAEC
analysis, resulting in a single Ara6 peak. (c)
14C-labelled AG digested with endoarabina-
nase showing three peaks as Ara2, Ara6 and
cyclic Gal4, as established by Xin et al. (1997).
A. G. Amin and others
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comparable to the retention time of the terminal
hexasaccharide Ara6 (Fig. 2b) released from the
14C-
labelled AG (Fig. 2c). This result confirmed the formation
of a heptamer by incorporating two Araf residues on the
pentasaccharide acceptor and was in full agreement with
the product formed and analysed for M. smegmatis
(Khasnobis et al., 2006). In the biosynthetic product,
which is a heptamer, there is only one site amenable to the
Cellulomonas endoarabinanase action yielding one labelled
Ara6 (Khasnobis et al., 2006) leaving behind one unlabelled
Ara with the octyl aglycon. The retention time of Ara6 is
close to cyclic Gal4, which will not be detected as this
acquires no radioactivity in this assay.
Neutral sugar and glycosyl linkage composition
Neutral sugar composition of AG from the DembAMsm
strain (1.2:1) showed diminution of the total Ara content
compared to the embAMtb-complemented strain (2.2:1)
which was in accordance with that of wild-type M.
smegmatis (Escuyer et al., 2001). The sugar composition
was calculated based on a single rhamnosyl (Rha) residue
per AG chain. DembAMsm had no significant effect on the
arabinosylation of LAM.
Purified LAM and soluble AG from DembAMsm and
DembAMsm complemented with embAMtb were per-O-
methylated and hydrolysed, reduced, acetylated and ana-
lysed by GC/MS to determine glycosyl linkage compositions.
Analysis of AG yielded a molar ratio of tAraf (8.7%), 2-Araf
(13.4%), 5-Araf (56.3%), 3,5-Araf (21.5%) for DembAMsm
and a molar ratio of tAraf (13.2%), 2-Araf (14.1%), 5-Araf
(52.6%), 3,5-Araf (20%) for DembAMsm complemented
with embAMtb. Thus complementation of the mutant with
embAMtb clearly resurrected the defect in tAraf, 2-Araf and
reduced 5-Araf which would occur if more branching is
introduced. These results are in agreement with the cell-free
assay, which resulted in the branched heptamer. We did not
observe any changes in the composition of LAM in both
DembAMsm and DembAMsm complemented with embAMtb.
Identification of the promoter for embA
The genomic organization of embA is shown in Fig. 1.
Previous work in M. smegmatis suggested that embA is
expressed either from its own promoter (Escuyer et al.,
2001) or from a polycistronic message encompassing the
embCAB region (Telenti et al., 1997). However, the
promoter(s) were never directly identified and no data
are available for M. tuberculosis. Other data suggest that the
EmbR regulatory protein binds to the upstream region of
embAMtb and that embA is subject to regulation by EmbR
in M. smegmatis (Sharma et al., 2006), although again, no
data are available for M. tuberculosis. Because these
experiments have not always been conducted in the native
host, we investigated expression of embAMtb in its native
host and in M. smegmatis.
To determine if a functional promoter for embA exists
immediately upstream of the gene, we cloned the embC and
embA intergenic region (Fig. 1) into the promoter-probe
vector pSM128 (Dussurget et al., 1999), an integrating
vector (which is therefore present in only one copy). We
assayed promoter activity of this region in M. smegmatis
and M. tuberculosis (Fig. 3). A functional promoter was
present in this region as assayed by b-galactosidase activity.
Interestingly, the activity of the promoter was significantly
different in the two species (P,0.05 using Student’s t-test),
with a sevenfold higher expression level in its native host
(M. tuberculosis). These results indicate that activity of the
embAMtb promoter is not equivalent in the two organisms.
A predicted 210 promoter sequence is found upstream of
embAMtb (Fig. 3a). We confirmed that this was a functional
promoter region using site-directed mutagenesis. Changing
the sequence TACCAT to GACCAG (pEMBA-M) resulted
in abolition of promoter activity, indicating that this is a
functional promoter region (Fig. 3).
embA is co-transcribed with embB in
M. tuberculosis
Our data showed that embA has its own promoter and
should be independent of embC. However, this did not
reveal whether embA and embB are co-expressed. We used
RT-PCR and Northern blotting to determine if embA was
co-transcribed with embC and embB. We first utilized RT-
PCR to determine if the genes were co-expressed. Primer
pair EMBAF1 and EMBBR spanning the embA–embB
junction was used; a 649 bp product was obtained,
indicating that a co-transcript is present. In contrast,
primer pair, EMBCF2 and EMBAR covering the embC–
embA junction did not give rise to a product, indicating a
lack of co-transcription (Fig. 3c). This result was confirmed
by Northern-blot analysis (Fig. 3d). A single transcript of
approximately 6.6 kb was detected using embA, corres-
ponding to the length of both embA and embB (6590 bp).
Thus our results demonstrate that embA is transcribed
independently of embC but is co-transcribed with embB.
Expression of PembA(Mtb) during different growth
phases
AG is a key component of the mycobacterial cell wall and it
is possible that different amounts may be required during
different growth phases, depending on the amount of cell
wall being newly synthesized. For example, during active
growth one would expect an increased requirement for new
cell wall biosynthesis. Similarly, biosynthesis of AG could be
reduced during stationary phase or in other non-replicating
conditions where cell division has ceased. In contrast, the
confirmation that embA is essential suggests that constitu-
tive expression should be required for cell survival.
We looked at PembA(Mtb) activity during growth and under
conditions of non-replicating persistence. Promoter
activity was measured in M. smegmatis and M. tuberculosis
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Promoter activity was measured over 158 days in liquid and
on solid media for M. tuberculosis.P embA(Mtb) was more
active in the cells grown on solid medium compared to
liquid medium. In both media, no significant variation in
activity was observed at different growth phases, indicating
that PembA(Mtb) is expressed toa constantlevelduringgrowth
and is not switched off during stationary phase (Fig. 4a). In
contrast, PembA(Mtb) activity was markedly downregulated
(tenfold) during a hypoxically induced non-replicating state
(Fig. 4c). A similar pattern of expression was seen during
growth in M. smegmatis, with constitutive expression
throughout the growth cycle, but at a lower level (Fig. 4b).
In contrast, a twofold upregulation of PembA(Mtb) was seen
under hypoxic conditions (P50.02) (Fig. 4c).
Stress and drug treatments do not induce
PembA(Mtb)
PembA(Mtb) activity was assayed in response to oxidative
stress generated by hydrogen peroxide exposure in M.
tuberculosis. For these experiments, catalase and albumin
were omitted from the media. No change in promoter
activity was seen (data not shown). The experiment was
also conducted in M. smegmatis, where no significant
changes were seen in response to 5, 10 or 15 mM hydrogen
peroxide exposure (data not shown).
Previous work has suggested that both embC and embB are
upregulated in response to ethambutol treatment, although
embA was not measured (Papavinasasundaram et al.,
2005). We looked at embA promoter activity after
ethambutol or ofloxacin treatment in M. tuberculosis (data
not shown). Antibiotics were added at 0.56 MIC. No
induction of promoter activity was seen in response to
ethambutol or ofloxacin treatment, demonstrating that
expression of embA is not controlled in response to
ethambutol exposure. Similarly, no induction of embA was
seen in M. smegmatis (data not shown).
DISCUSSION
Essentiality of embA in M. tuberculosis
embA is a non-essential gene in M. smegmatis, although
embA knockouts show an altered morphology and a slower
Fig. 3. Promoter activity of the embA
upstream region. (a) Sequence of the
embCA intergenic region carrying PembA(Mtb).
The stop and start codons of embC and embA
are underlined; the predicted ”10 region is in
large text. The bases in bold were mutated to
Gs in plasmid pEMBA-M. (b) Promoter activity
from PembA(Mtb) in M. smegmatis and M.
tuberculosis. M. smegmatis transformants
were grown in 10 ml 7H9-OADC for 30 h.
M. tuberculosis transformants were grown in
10 ml stationary cultures of 7H9-OADC-Tw
for 14 days. Results are the means±SD of
three individual transformants each assayed in
duplicate and are expressed as Miller units. (c)
RT-PCR analysis. Agarose gel analysis of RT-
PCR on the embC–embA and embA–embB
junctions of the embCAB locus. PCR with
primers EMBCF2 and EMBAR failed to pro-
duce the expected 0.795 kb product (lane 1)
while the primer pair EMBAF1 and EMBBR
produced the expected 0.649 kb product
(lane 2). Lane M is a 1 kb DNA ladder. (d)
Genetic organization of the emb region on the
M. tuberculosis chromosome and Northern
analysis of total RNA from M. tuberculosis
hybridized to labelled embA.
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wall permeability are affected (Escuyer et al., 2001). It is
not immediately obvious why EmbA plays a more critical
role in M. tuberculosis. One possibility is that EmbB in M.
smegmatis is able to function independently of EmbA, so
that deletion of one enzyme is possible. This hypothesis is
supported by the fact that a double embAB mutant could
not be constructed in M. smegmatis (unpublished data). In
M. tuberculosis, it is clear that EmbB cannot complement
the function of EmbA. We have also attempted to delete
embB in M. tuberculosis, but have been unsuccessful,
indicating that it may also be independently essential.
Differential expression of PembA(Mtb) in
M. smegmatis
We have shown that embAMtb has its own promoter and so
can be independently expressed from embC and possibly
embB. The activity of the M. tuberculosis promoter was
markedly different in M. smegmatis, indicating that the
latter species is not a good genetic model for the study of
embA. In particular, the overall level of expression of
PembA(Mtb) was sevenfold lower in M. smegmatis. Recent
work has suggested that PknH, a serine threonine kinase, is
responsible for the phosphorylation of EmbR, which in
turn is required for positive control of the embCAB genes
(Sharma et al., 2006). M. smegmatis does not possess a
homologue of PknH and this may explain partly why
PembA(Mtb) is underexpressed in this background. The
differential activity of the promoter in the two species in
response to hypoxia could also be attributed to the lack of
PknH, although the hypoxic response of M. smegmatis is
not exactly the same as M. tuberculosis (Wayne & Sohaskey,
2001).
In conclusion, we have demonstrated that even though the
gene products for the embA arabinosyltransferase in M.
tuberculosis and M. smegmatis are similar, there are
significant differences between the physiological require-
ments. In addition, the M. tuberculosis embA promoter is
constitutively active, but differentially expressed in M.
smegmatis. Further work using conditional expression
systems as developed recently (Blokpoel et al., 2005;
Carroll et al., 2005; Ehrt et al., 2005) could help to
determine why this arabinosyltransferase is critical for the
survival of tubercle bacilli.
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